Nanoparticles in excipients and their potential impact on patients and pharmaceuticals

In order to ensure the safety of patients, the toxicological risk assessment needs to thoroughly evaluate all potential risks which may be caused by any component present in a pharmaceutical drug product.

Single cell cloning (SCC) is a critical and high-value process for an increasing number of applications including cell engineering; stable cell lines for therapeutic mAbs and biosimilars; vector production for gene therapy; and many more. During this webinar, Tom Kelly from Janssen (part of Johnson & Johnson) will talk about his use of Solentim’s VIPS™ (Verified in-situ Plate Seeding) system, the world’s first All-in-One Single Cell Cloning System. He will explain why Janssen moved away from older generation CLD technology using Clonepix, which was based on detecting and picking high-producer clones in semi-solid media.

This event will showcase how nations have coordinated pharmacy support for person-centred care in the fight against COVID-19 with a focus on strategy, policy and practice.

Learn more on burn injury, prevention and the immediate care needed for patients with burn injuries. In the United States, approximately 486,000 people seek medical treatment for burns each year. Many people may not recognize their risk of burn injury. This material will review burn injuries, including types of burns and immediate care for burns and explore the effect of burn injuries on the pulmonary, cardiac, and renal systems. It will cover the classification system used for burn injuries describe the local and systemic effects of a major burn injury, discuss the potential fluid and electrolyte alterations of the emergent/resuscitative and acute phases of burn management, describe care of the patient with burn injuries, and identify the appropriate patient referral to a burn center.